Giulio Evangelisti

ORCID: 0000-0001-8075-7916 · 20 papers in corpus · active 2018-2026

Study types

  • article 8
  • review 8
  • book-chapter 3
  • other 1

Condition tags

  • endometriosis 16
  • mesh:D004715 8
  • adenomyosis 2
  • mesh:D017699 1
  • endometrioma 1
  • dysmenorrhea 1
  • dyspareunia 1
  • chronic_pelvic_pain 1
  • infertility 1
review 2026
Expert opinion on drug safety ·doi:10.1080/14740338.2026.2627190

INTRODUCTION: Hormonal therapy is the cornerstone of long-term endometriosis management, especially for women deferring surgery. In patients with comorbid migraine - a common, disabling condition - therapeutic choices must balance efficacy …

review 2025
Expert opinion on drug safety ·doi:10.1080/14740338.2025.2547017

INTRODUCTION: Medical therapy is crucial in the long-term management of endometriosis, and its clinical efficacy must be balanced with a favorable safety profile. AREAS COVERED: This review aims to provide a comprehensive overview of availa…

article 2025
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70274

OBJECTIVE: The objective of the current study was to evaluate the "twisting sign," defined as uterine fundus rotation observed on transvaginal sonography (TVS), as a potential soft marker for deep endometriosis (DE) and its association with…

book-chapter 2024
·doi:10.1007/978-3-031-50662-8_8
article 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102493

Deep endometriosis (DE) can be localized in the parametrium, a complex bilateral anatomical structure, sometimes necessitating intricate surgical intervention due to the potential involvement of autonomic nerves, uterine artery, and ureter.…

review 2023
Expert opinion on emerging drugs ·doi:10.1080/14728214.2023.2296080

INTRODUCTION: Endometriosis is an estrogen-dependent disease that gives rise to pelvic pain and infertility. Although estroprogestins and progestins currently stand as the first-line treatments for this condition, demonstrating efficacy in …

review 2023
Drugs ·doi:10.1007/s40265-023-01957-7

Adenomyosis, characterized by the growth of endometrial tissue within the uterine wall, poses significant challenges in treatment. The literature primarily focuses on managing abnormal uterine bleeding (AUB) and dysmenorrhea, the main sympt…

other 2022
Journal of clinical medicine ·doi:10.3390/jcm11113214

The aim of this study was to assess the prevalence of adenomyosis in symptomatic women in relation to the angle of flexion of the uterus. A total of 120 patients referring to our Chronic Pelvic Pain Center were prospectively enrolled. Each …

review 2022
Expert opinion on drug metabolism & toxicology ·doi:10.1080/17425255.2022.2113381

INTRODUCTION: Uterine fibroids are the most common benign gynecological tumors affecting women of reproductive ages. Although surgery is the definitive treatment choice, several medical approaches have been investigated to control their sym…

book-chapter 2022
·doi:10.1201/9780429488115-7

Medical therapy has a pivotal role in the long-term treatment of endometriosis-associated pain. Combined oral contraceptives and progestins, available for multiple routes of administration, are effective first-line therapies. Several random…

article 2021
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14209

INTRODUCTION: Preoperative assessment of deep endometriotic (DE) nodules is necessary to inform patients about the possible treatments and provide informed consent in case of surgery. This study aims to investigate the diagnostic performanc…

review 2021
Expert opinion on investigational drugs ·doi:10.1080/13543784.2021.1957830

INTRODUCTION: Uterine myomas and endometriosis are benign hormone-dependent diseases affecting women of reproductive age. Substantial efforts have been made to develop innovative medical options for treating these gynecologic diseases. Elag…

article 2021
·doi:10.1358/dof.2021.46.11.3331001
book-chapter 2021
·doi:10.1016/b978-0-12-820661-4.00010-8
article 2020
·doi:10.1016/j.fertnstert.2020.08.583
article 2020
·doi:10.1016/j.fertnstert.2020.08.697
review 2020
Expert opinion on drug metabolism & toxicology ·doi:10.1080/17425255.2020.1789591

INTRODUCTION: The second-line treatment of endometriosis-related pain symptoms includes injectable depot formulations of gonadotropin-releasing hormone analogs (GnRH-as). These drugs improve the symptomatology by inducing a hypoestrogenic s…

article 2020
Clinical and experimental reproductive medicine ·doi:10.5653/cerm.2019.03342

therapeutic target for this benign hormone-dependent disease Further studies are needed to draw definitive conclusions on the relationship between endometriosis and vitamin D.

article 2018
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia ·doi:10.1055/s-0038-1675197

Publication in the conference proceedings of EUSIPCO, Bucharest, Romania, 2012

review 2018
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2018.1494154

INTRODUCTION: Pharmacotherapy has a pivotal role in the management of endometriosis with long-term treatments balancing clinical efficacy (control of pain symptoms and prevention of recurrence of the disease after surgery) with an acceptabl…